Steven Wheen
Stock Analyst at Jarden
(3.86)
# 1,899
Out of 4,504 analysts
229
Total ratings
45.3%
Success rate
8.4%
Average return
Main Sectors:
Stocks Rated by Steven Wheen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: RMD ResMed Inc. | Maintained: Buy | $42.70 → $40.20 | $28.44 | +41.35% | 22 | Jul 8, 2026 | |
| ASX: REG Regis Healthcare Limited | Downgraded: Hold | $8.50 → $7.50 | $6.18 | +21.36% | 16 | Jun 18, 2026 | |
| ASX: SHL Sonic Healthcare Limited | Maintained: Hold | $21.90 → $22.30 | $20.85 | +6.98% | 29 | Jun 15, 2026 | |
| ASX: HLS Healius Limited | Maintained: Sell | $0.77 → $0.47 | $0.38 | +23.68% | 32 | May 14, 2026 | |
| ASX: CSL CSL Limited | Downgraded: Hold | $244.00 → $191.00 | $120.52 | +58.48% | 33 | May 12, 2026 | |
| ASX: COH Cochlear Limited | Maintained: Hold | $224.00 → $169.00 | $122.61 | +37.84% | 16 | Apr 22, 2026 | |
| ASX: TLX Telix Pharmaceuticals Limited | Maintained: Buy | $21.00 → $21.80 | $16.05 | +35.87% | 29 | Apr 7, 2026 | |
| ASX: RHC Ramsay Health Care Limited | Maintained: Buy | $40.60 → $45.20 | $42.15 | +7.24% | 25 | Feb 27, 2026 | |
| ASX: IDX Integral Diagnostics Limited | Maintained: Buy | $3.35 → $3.25 | $2.07 | +57.00% | 23 | Feb 25, 2026 | |
| ASX: QUB Qube Holdings Limited | Maintained: Hold | $5.00 | $5.11 | -2.15% | 1 | Feb 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $22.00 | $25.41 | -13.42% | 1 | Feb 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $0.71 → $0.75 | $0.59 | n/a | 2 | Nov 27, 2024 |
ResMed Inc.
Jul 8, 2026
Maintained: Buy
Price Target: $42.70 → $40.20
Current: $28.44
Upside: +41.35%
Regis Healthcare Limited
Jun 18, 2026
Downgraded: Hold
Price Target: $8.50 → $7.50
Current: $6.18
Upside: +21.36%
Sonic Healthcare Limited
Jun 15, 2026
Maintained: Hold
Price Target: $21.90 → $22.30
Current: $20.85
Upside: +6.98%
Healius Limited
May 14, 2026
Maintained: Sell
Price Target: $0.77 → $0.47
Current: $0.38
Upside: +23.68%
CSL Limited
May 12, 2026
Downgraded: Hold
Price Target: $244.00 → $191.00
Current: $120.52
Upside: +58.48%
Cochlear Limited
Apr 22, 2026
Maintained: Hold
Price Target: $224.00 → $169.00
Current: $122.61
Upside: +37.84%
Telix Pharmaceuticals Limited
Apr 7, 2026
Maintained: Buy
Price Target: $21.00 → $21.80
Current: $16.05
Upside: +35.87%
Ramsay Health Care Limited
Feb 27, 2026
Maintained: Buy
Price Target: $40.60 → $45.20
Current: $42.15
Upside: +7.24%
Integral Diagnostics Limited
Feb 25, 2026
Maintained: Buy
Price Target: $3.35 → $3.25
Current: $2.07
Upside: +57.00%
Qube Holdings Limited
Feb 20, 2026
Maintained: Hold
Price Target: $5.00
Current: $5.11
Upside: -2.15%
Feb 20, 2026
Maintained: Hold
Price Target: $22.00
Current: $25.41
Upside: -13.42%
Nov 27, 2024
Maintained: Hold
Price Target: $0.71 → $0.75
Current: $0.59
Upside: n/a